Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 11/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | RXRA | P19793 | 1/20 | 0.46 |
| ▸ | RXRB | P28702 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6231803 | 1.00 | PPARD (0.54) | PPARDNPSR1ALDH1A1LMNAHTT | |
| SCHEMBL6539039 | 0.88 | NPSR1 (0.54) | PPARDNPSR1ALDH1A1LMNAHTT | |
| SCHEMBL6539010 | 0.88 | PPARD (0.50) | PPARDNPSR1ALDH1A1LMNAHTT | |
| SCHEMBL5586019 | 0.86 | PPARD (0.52) | PPARDLMNARXRARXRBMAPK1 | |
| SCHEMBL6539023 | 0.86 | L3MBTL1 (0.48) | PPARDNPSR1ALDH1A1LMNAHTT | |
| SCHEMBL6538800 | 0.86 | PPARD (0.57) | PPARDNPSR1ALDH1A1LMNAHTT | |
| SCHEMBL6538946 | 0.85 | PPARD (0.56) | PPARDNPSR1ALDH1A1LMNAHTT | |
| SCHEMBL6207736 | 0.84 | NPSR1 (0.54) | PPARDNPSR1ALDH1A1LMNAHTT | |
| SCHEMBL6540515 | 0.84 | PPARD (0.53) | PPARDRXRARXRBMAPK1 | |
| SCHEMBL6208499 | 0.83 | NPSR1 (0.56) | PPARDNPSR1ALDH1A1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040157891-A1 | Inhibitor of cox | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157891-A1 | Inhibitor of cox | PTGS1, PTGS2, PTGES2 | PPARD 1747/4885NPSR1 884/4885ALDH1A1 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.